Neuralink last raised a 280-million-dollar Series D funding round in 2023, with an additional 43-million-dollar tranche added months later. The company said it has now conducted more human clinical ...

Paradromics completes first human BCI implant, setting stage for clinical trials targeting severe motor impairment.

Elon Musk's Neuralink said on Monday that it had raised $650 million in its latest funding round as its brain implant device ...

Paradromics, a competitor of Neuralink, announced Monday it safely implanted a brain-computer interface into a human patient ...

Elon Musk’s startup deepens ambitions in human-AI integration amid growing competition from Paradromics and others Neuralink, ...

Elon Musk's Neuralink said on Monday that it had raised $650 million in its latest funding round as its brain implant device ...

Paradromics implanted—then removed—the device in an epileptic patient. The goal is to help people with conditions like ALS.

Elon Musk's brain chip implant startup Neuralink raised a $650 million Series E funding round, the company announced.

Neuralink is building a brain-computer interface, or BCI, which is a system that translates brain signals into commands for ...

Neuralink competitor Paradromics plans to conduct the first clinical trial of its Connexus brain implant later this year.

Paradromics Inc. completed its first human procedure with the Connexus BCI, marking a milestone in brain-computer interface ...

Neuralink, a neurotechnology company founded by Tesla ( NASDAQ: TSLA) CEO Elon Musk, raised $650M through its latest Series E ...